secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2023-11-29T23:59:59+00:00
Accession:  0001493152-23-043068
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera receives Nasdaq delisting notice for equity below $2.5M minimum
---------------------------------------------------------------------------

- Stockholders' equity as of Sep 30, 2023 was $1,038,000, below Nasdaq's $2.5M requirement.
- Company also failed alternative compliance metrics: market value of listed securities <$35M and net income.
- No immediate effect on listing; 45 days to submit a compliance plan to Nasdaq.
- If plan accepted, company may have up to 180 days from Nov 22, 2023 to regain compliance.
- If plan rejected, company may appeal to a Nasdaq Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223043068/0001493152-23-043068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223043068/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-043068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer